Editorial Commentary
Targeting MET amplification in non–small cell lung cancer: encouraging results with vebreltinib from the phase II KUNPENG study
Translational Lung Cancer Research
2026;
15
(6)
:160
.
(30 June 2026)
Is TROP2 ADC ready for EGFR-TKI-resistant NSCLC?
Translational Lung Cancer Research
2026;
15
(6)
:161
.
(30 June 2026)
Original Article
A retrospective cohort study of operated older patients undergoing lung resection after PFT-based versus CPET-based preoperative stratification
Translational Lung Cancer Research
2026;
15
(6)
:162
.
(30 June 2026)
Neoadjuvant therapy followed by tracheal/carinal resection and reconstruction: perioperative and long-term outcomes
Translational Lung Cancer Research
2026;
15
(6)
:163
.
(30 June 2026)
Neoadjuvant chemoimmunotherapy in resected stage III non-small-cell lung cancer: real-world data from a nationwide registry
Translational Lung Cancer Research
2026;
15
(6)
:164
.
(30 June 2026)
Tumor-distant pulmonary immune landscapes are associated with postoperative outcomes in non-small cell lung cancer
Translational Lung Cancer Research
2026;
15
(6)
:165
.
(30 June 2026)
Computed tomography-based deep learning prediction of radiation-induced functional decline after lung cancer radiotherapy
Translational Lung Cancer Research
2026;
15
(6)
:166
.
(30 June 2026)
LPIN2 contributes to tyrosine kinase inhibitor resistance via activation of PI3K pathway
Translational Lung Cancer Research
2026;
15
(6)
:167
.
(30 June 2026)
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis
Translational Lung Cancer Research
2026;
15
(6)
:168
.
(30 June 2026)
Development and validation of a dual-attention deep learning prediction model for noninvasive differentiation of pulmonary invasive mucinous adenocarcinoma from inflammatory pulmonary nodules
Translational Lung Cancer Research
2026;
15
(6)
:169
.
(30 June 2026)
Osalmid inhibits lung adenocarcinoma progression and enhances EGFR-TKI responses: a preclinical and translational study
Translational Lung Cancer Research
2026;
15
(6)
:170
.
(30 June 2026)
Prediction of peak oxygen uptake using interpretable machine learning on routinely available preoperative assessments before lung resection
Translational Lung Cancer Research
2026;
15
(6)
:171
.
(30 June 2026)
A recurrence risk prediction model and recurrence patterns in pulmonary lymphoepithelial carcinoma based on clinical and dynamic hematologic parameters
Translational Lung Cancer Research
2026;
15
(6)
:172
.
(30 June 2026)
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study
Translational Lung Cancer Research
2026;
15
(6)
:173
.
(30 June 2026)
The impact of local tumor immune responses on prognosis in resected lung adenocarcinoma
Translational Lung Cancer Research
2026;
15
(6)
:174
.
(30 June 2026)
Ultrasound assessment of pleural invasion via visceral pleura interruption and arch distance-to-tumour diameter ratio in a rabbit model of subpleural lung cancer
Translational Lung Cancer Research
2026;
15
(6)
:175
.
(30 June 2026)
Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study
Translational Lung Cancer Research
2026;
15
(6)
:176
.
(30 June 2026)
Lobectomy, segmentectomy, and wedge resection for elderly patients with solid-predominant stage I NSCLC: survival, pulmonary function, and postoperative outcomes
Translational Lung Cancer Research
2026;
15
(6)
:177
.
(30 June 2026)
Development and validation of a PET/CT radiomics and dual-task learning model for the prediction of pathological subtypes and EGFR mutation in non-small cell lung cancer
Translational Lung Cancer Research
2026;
15
(6)
:178
.
(30 June 2026)
Prognostic analysis and beneficiary population exploration of subsequent treatment regimens after third-generation EGFR-TKIs failure in EGFR-mutated advanced non-small cell lung cancer: a retrospective cohort study
Translational Lung Cancer Research
2026;
15
(6)
:179
.
(30 June 2026)
Impact of chronic obstructive pulmonary disease on the prognosis of patients with extensive-stage small-cell lung cancer treated with chemoimmunotherapy
Translational Lung Cancer Research
2026;
15
(6)
:180
.
(30 June 2026)
Study Protocol
Consolidation thoracic radiotherapy following quadruple induction with benmelstobart, anlotinib, and chemotherapy for extensive-stage small cell lung cancer: rationale and protocol of a phase II study
Translational Lung Cancer Research
2026;
15
(6)
:181
.
(30 June 2026)
Review Article
Inconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review
Translational Lung Cancer Research
2026;
15
(6)
:182
.
(30 June 2026)
Current advances in extended resections for non-small cell lung cancer—a narrative review
Translational Lung Cancer Research
2026;
15
(6)
:183
.
(30 June 2026)
A narrative review on CT-based evaluation and prediction of lung nodule growth: current status and future directions
Translational Lung Cancer Research
2026;
15
(6)
:184
.
(30 June 2026)
Over- and underscreening for lung cancer
Translational Lung Cancer Research
2026;
15
(6)
:185
.
(30 June 2026)
Case Report
Complete response in disseminated EGFR-mutated lung adenocarcinoma through chemosensitivity-guided chemotherapy, osimertinib, and stereotactic ablative body radiotherapy: a case report
Translational Lung Cancer Research
2026;
15
(6)
:186
.
(30 June 2026)
Atypical type D extended sleeve resection after neoadjuvant chemoimmunotherapy in a 69-year-old man with locally advanced lung cancer and a tracheobronchial branching anomaly: a case report
Translational Lung Cancer Research
2026;
15
(6)
:187
.
(30 June 2026)
Remarkable response to personalized combination immunotherapy of nivolumab plus ipilimumab in an 84-year-old patient with locally advanced squamous cell carcinoma: a case report
Translational Lung Cancer Research
2026;
15
(6)
:188
.
(30 June 2026)
Cisplatin re-challenge following recovery from carboplatin-induced, biopsy-proven acute tubular necrosis in a 57-year-old patient with squamous-transformed non-small cell lung cancer: a case report
Translational Lung Cancer Research
2026;
15
(6)
:189
.
(30 June 2026)
Letter to the Editor
Refining the clinical interpretation of GLUT1 in non-small cell lung cancer
Translational Lung Cancer Research
2026;
15
(6)
:190
.
(30 June 2026)
